Thiophene substituted chalcones (1a-e) were cyclised with thiourea in presence of potassium hydroxide to get 4-substituted-6-(thiophen-2-yl)pyrimidine-2-thiols (2a-e) which were then stirred with methyl iodide to obtain 4-substituted-2-(methylsulfanyl)-6-(thiophen-2-yl)pyrimidines (3a-e). Compounds (3a-e) were refluxed with different N-methylpiperazine and N-phenylpiperazine to afford 4-substituted-2-(4-methylpiperazin-1-yl)-6-(thiophen-2-yl) pyrimidines (4a-e) and 4-substituted-2-(4-phenylpiperazin-1-yl)-6-(thiophen-2-yl)pyrimidines (5a-e). The structures of all the newly synthesised compounds 4b, 4d, 5a and 5b showed good antibacterial activity at 40µg/mlconcentration. Compounds 4a, 4d, 4e, 5c and 5e showed significant antifungal activity at 40 µg/ml concentration compared with standard drugs.
Research Paper
Piperazines have a long and distinguished history extending from the days of their discovery as important pharmacophore in chemotherapy. The medicinal value of piperazine derivatives is significant among various heterocycles, as they are found to possess various biological activities [1] [2] [3] [4] [5] [6] [7] [8] [9] . Moreover, several bis (heteroaryl) piperazine derivatives (BHAP) have been introduced as potent antiHIV drugs [10, 11] . In addition, fused pyrimidines have been reported to exhibit important biological activities [12, 13] . These facts contemplated us for the synthesis of novel pyrimidine derivatives incorporating piperazine moiety to explore their biological activities resulting in efficient bio molecules with minimum side effects.
MATERIALS AND METHODS
Melting points are determined in an open capillary and are uncorrected (Tables 1 and 2 ). IR spectra were recorded on Bruker alpha FTIR spectrophotometer, 1 H NMR and 13 C NMR spectra were measured on Bruker AV 400MHz using CDCl 3 and DMSO as solvent, respectively. Chemical shifts are expressed in δ ppm. Mass spectra were recorded on a Joel JMS-D 300 mass spectrometer operating at 70 eV. The reactions were followed and checked by TLC and further purification was done by column chromatography. The reagents used were of AR grade and they have been purified by distillation.
The reaction mixture was cooled, and poured into ice cold water with stirring. The product was filtered, dried and recrystallized using ethanol gave pure crystalline solid 2a. Same procedure was followed for compounds 2b-e from 1b-e.
Synthesis of 4-(4-methoxyphenyl)-2-(methylsulfanyl)-6-(thiophen-2-yl)pyrimidine (3a):
To a solution of 4-(4-methoxyphenyl)-6-(thiophen-2-yl)pyrimidine-2-thiol (2a)(3.0 g. 0.01 mol) in dimethyl formamide (20 ml), potassium carbonate (2.76 g, 0.02 mol) and methyl iodide (2.84 g, 0.02 mol) were added and stirred for 4 h. Reaction time and completion of reaction was monitored by TLC. Then reaction mixture was diluted with cold water and neutralised by glacial acetic acid. The product was filtered off, dried and recrystallized from ethanol to give pure crystalline solid 3a.
Same procedure was followed for compounds 3b-e from 2b-e.
Synthesis of 4-(4-methoxyphenyl)-2-(4-methylpiperazin-1-yl)-6-(thiophen-2-yl)pyrimidine (4a):
4-(4-Methoxyphenyl)-2-(methylsulfanyl)-6-(thiophen-2-yl)pyrimidine (3a)(0.314 g, 0.001 mol) and N-methylpiperazine ( 0.1 ml, 0.001 mol) in dry ethanol (15 ml) were taken in a round bottomed flask and the reaction mixture was refluxed for 12 h in presence of catalytic amount of potassium hydroxide. After completion of reaction, it was then poured into crushed ice. The solid separated was filtered, dried and recrystallized using ethanol to give pure crystalline solid 4a. Same procedure was followed for compounds 4b-e from 3b-e. 
Synthesis of 4-(4-methoxyphenyl)-2-(4-phenylpiperazin-1-yl)-6-(thiophen-2-yl)pyrimidine (5a):
4-(4-Methoxyphenyl)-2-(methylsulfanyl)-6-(thiophen-2-yl)pyrimidine (3a)(0.314 g, 0.001 mol) and N-phenylpiperazine (0.16 ml, 0.001 mol) in dry ethanol (15 ml) were taken in a round bottomed flask and the reaction mixture was refluxed for 12 h in presence of catalytic amount of potassium hydroxide. After completion of reaction, it was then poured into crushed ice. The solid separated was filtered, dried and recrystallized using ethanol to give pure crystalline solid 5a. Same procedure was followed for compounds 5b-e from 3b-e. 
Characteristics of 1a-e:

Antibacterial activity:
Some selected compounds were screened for their in vitro antibacterialactivityagainst Gram positive bacteria namely Staphylococcus aureus (NCIM2492), Bacillus subtilis (NCIM2088) and Gram negative bacteria Escherichia coli (NCIM2138) and Salmonella paratyphi-A (ATCC3220). The activity was carried out using the cup-plate agar diffusion method [14] . The test compounds were dissolved in dimethyl formamide to obtain a solution of 40 μg/ml concentration. The inhibition zones of microbial growth produced by different compounds were measured in millimetres at the end of an incubation period of 48 h at 38º dimethyl formamide alone showed no inhibition zone. Choramphenicol was employed as reference standard (40 μg/ml) to evaluate the potency of tested compounds. The results are illustrated inthe Table 3 .
Antifungal activity:
Some selected compounds were screened for theirantifungal activity against fungi Aspergillus niger (ATCC9687), Pencillium notatum (NCIM746), Aspergillus fumigates (ATCC9389) and Candida albicans (NCIM3466).The activity was carried out using the cup-plate agar diffusion method [14] . The test compounds were dissolved in dimethyl formamide to obtain a solution of 40 μg/ml concentration. The inhibition zones of fungal growth produced by different compounds were measured in millimetres at the end of an incubation period of 48 h at 38º. Dimethyl formamide alone showed no inhibition zone. Fluconazole was employed as reference standard and results were shown in Table 4 . Most of the tested compounds showed significant antifungal activity comparable with that of the standard drug fluconazole. The investigation of antibacterial and antifungal screening data revealed that the some selected compounds showed moderate to good inhibition at 4a  14  08  10  12  4b  16  13  15  17  4c  11  12  14  18  4d  18  14  16  15  4e  11  12  15  16  5a  19  13  15  15  5b  17  13  17  17  5c  14  10  15  15  5d  10  10  12  18  5e  12  10  13  11  DMF  00  00  00  00  Chloramphenicol  20  14  18  22 Chloramphenicol was as use as standard and dimethylformamide was as used as control, zone of inhibition expressed in mm. The cup plate method was followed and chloramphenicol was used as standard. The concentration of the drug used is 40 μg/ml, DMF: dimethyl formamide 4a  22  21  23  17  4b  19  12  15  16  4c  20  20  19  14  4d  20  22  22  16  4e  23  21  23  15  5a  19  19  20  16  5b  12  19  18  14  5c  22  20  19  15  5d  15  18  15  13  5e  23  23  18  19  DMF  00  00  00  00  Fluconazole  25  25  25  19 Fluconazole was use as standard and dimethylformamide was used as control, zone of inhibition expressed in mm. The cup plate method was followed and fluconazole was used as standard. The concentration of the drug used is 40 μg/ml, DMF: dimethyl formamide 40 μg/ml concentration. However the activity was less compared to the standard drugs.
RESULTS AND DISCUSSION
In this article, we reported the synthesis and biological properties of some pyrimidine linked piperazine derivatives (Scheme 1). The chalcones (1a-e) have been prepared by refluxing 2-acetylthiophene with aromatic aldehydes in presence of potassium hydroxide in ethanol medium. All the chalcones have been characterised by elemental analysis and spectral studies.
Compounds (1a-e) were then refluxed with thiourea in presence of acetic acid in 1,4-dioxane solvent to afford 4-substituted-6-(thiophen-2-yl)pyrimidine-2-thiols (2a-e) in good yield. The formation of (2a-e) was monitored by TLC. Compound(2a) exhibited absorption band at 2363 cm -1 corresponding to SH stretching in its IR spectrum. The 1 H NMR spectrum showed a singlet at 3.86 δ due to three protons of OCH 3 group and a singlet at 12.50 δ due to one protons of SH group. Further, a molecular ion peak at m/z 300 in its mass spectrum is in agreement with the structure.
4-Substituted-2-(methylsulfanyl)-6-(thiophen-2-yl)pyrimidines (3a-e) were prepared by the treatment of (2a-e) with methyliodide in presence of potassium carbonate in dimethyl formamide medium. The IR spectrum of (3a) exhibited an absorption band at 827 cm -1 due to C-S-C group. The 1 H NMR spectrum of compound (3a) showed a singlet at 3.85 δ due to three protons of OCH 3 group and singlets at 2.17 δ for three protons of one SCH 3 group. Further, it showed a molecular ion peak at m/z 314 in its mass spectrum is in agreement with the structure.
Compounds
(3a-e) on refluxion with N-methylpiperazine and N-phenylpiperazine in presence of catalytic amount of potassium hydroxide produced 4-substituted-2-(4-methylpiperazin-1-yl)-6-(thiophen-2-yl)pyrimidines (4a-e) and 4-substituted-2-(4-phenylpiperazin-1-yl)-6-(thiophen-2-yl)pyrimidines derivatives (5a-e). The reactions were monitored by TLC. In confirmation, the IR spectrum of (4a) absorption band at 1120cm -1 due to C-N-C group. The 1 H NMR spectrum showed a singlet at 3.88 δ due to three protons of OCH 3 group, a singlet at 2.45 δ due to three protons NCH 3 group and two triplets in the range 2.80-3.25 δ for eight piperazine protons. Its mass spectrum showed a molecular ion peak at m/z 366 which is in agreement with the structure. The IR spectrum of (5a) absorption band at 1125 cm -1 due to C-N-C group. The 1 H NMR spectrum showed a singlet at δ 3.80 due to three protons of OCH 3 group, two triplets in the range δ 2.85-3.25 for eight piperazine protons. Its mass spectra showed a molecular ion peak at m/z 428 which is in agreement with the structure.
The compounds 4b, 4d, 5a and 5b showed good antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Salmonella paratyphi-A at 40 μg/ml concentration. Compounds 4a, 4d, 4e, 5c and 5e showed significant antifungal activity against Aspergillus niger, Pencillium notatum, Aspergillus fumigates and Candida albicans at 40 μg/ml concentration. However the activity was less compared to the standard drug. The data of these studies is summarized in Tables 3 and 4 .
The standard drugs chloramphenicol and fluconazole have structural analogues of synthesized piperazine derivatives. Due to the presence of electronegativity functionality such as nitrogen, oxygen and sulphur containing heterocyclic ringsin the synthesized compounds, it enhances the antimicrobial activity.
In conclusion, in the present work, thiophene substituted chalcones (1a-e) were cyclised with thiourea in presence of potassium hydroxide to get
